PROBLEM OF THE YEAR:

SARS-CoV-2 Pandemia – Vaccination against Coronavirus in Patients with Cancer

Speaker: Ursula Wiedermann-Schmidt

BREAKTHROUGH OF THE YEAR:

Targeting KRAS Mutations

Speaker: Martin Filipits

New Compounds of the Year: Entrectinib

Speaker: Artur Bandura

New Compounds of the Year: Cabozantinib

Speaker: Bela Mrinakova

Speaker: Gerald Prager, Austria
Discussants: Eric van Cutsem, Belgium / Junji Furuse, Japan

Combining Immune Checkpoint Inhibitors with Tyrosine Kinase Inhibitors

Speaker: Thorsten Füreder

Sequence of Treatment for Metastatic Prostate Cancer Revisited

Speaker: Gero Kramer

New Compounds of the Year: Lenvatinib

Speaker: Adrian Perdyan

ADVANCES IN IMMUNOTHERAPY:

Maintenance Treatment of Ovarian Cancer

Speaker: Christoph Grimm

Adjuvant Treatment of Colon Cancer – for how long and for whom (not)?

Speaker: Gerald Prager

Positioning Immune Checkpoint Inhibitor Treatment for Breast Cancer

Speaker: Rupert Bartsch

From Bench to Bedside: Chronic Lymphocytic Leukemia

Speaker: Ulrich Jäger

ADVANCES IN IMMUNOTHERAPY:

How to optimize immunotherapy for advanced NSCLC in daily practice?

Speaker: Tanja Cufer

ADVANCES IN IMMUNOTHERAPY:

Neoadjuvant Treatment with Immune Checkpoint Inhibitors

Speaker: Christoph Zielinski

Speaker: Talia Golan, Israel

Discussants:  Eric van Cutsem, Belgium  / Changhoon YOO, Korea

Speaker: Andrea Davis, UK
Discussants: Dominiek De Jonckheere, Belgium / Phil Whelan, UK

Speaker: Cindy Neuzillet, France

Discussants: Pascal Hammel, France

Masafumi Ikeda, Japan

Speaker: Thomas Seufferlein, Germany

Discussants: Massimo Falconi, Italy

Katsuhiko Uesaka, Japan

Speaker: Francesca Pesce, Italy

Discussants: Ali Stunt, UK / Gerald Prager, Austria

Speaker: Julien Taieb, France

Discussants: Harpreet Wasan, UK / Joon Oh Park, Korea

Speaker: Teresa Macarulla, Spain

Discussants: Eric Van Cutsem, Belgium / Chee Cheng Ean, Singapore

Host: Christoph Zielinski
Faculty: Rupert Bartsch, Martine Piccart, Evandro De Azambuja, Leticia De Mattos-Arrudas

PANCREAS CANCER ACADEMY 2020 – Panel discussion:  Advocates only

PANCREAS CANCER ACADEMY 2020 –

How COVID-19 affects Pancreas Cancer  Patients!

Our latest webinar, analyzing findings presented at the ESMO annual meeting 2020 on breast-cancer.

After Immun Checkpoint Inhibitors and the concept of it has been awarded a Nobel Prize two years ago, the CECOG “Immuno Oncology Training” Webinar covers very impressive and important advances in the field of Immuno Oncology. The faculty consists of Prof. Walter Berger, Prof. Wolfgang Köstler, Prof. Manuela Schmidinger and Prof. Christoph Zielinski.

Prof. Dr. Heinrich Resch talks about “The Concept of Skeletal Health – a sine qua non in Cancer Care”.

This Presentation is part of the “Bone Health in Cancer Patients in Times of COVID 19” Webinar.

Prof. Dr. Peter Dubsky talks about “Skeletal Health in Breast Cancer”.

This Presentation is part of the “Bone Health in Cancer Patients in Times of COVID 19” Webinar.

Prof. Dr. Daniele Santini talks about “Skeletal Health in Prostate Cancer”.

This Presentation is part of the “Bone Health in Cancer Patients in Times of COVID 19” Webinar.

Prof. Dr. Jelena Spasic talks about “Skeletal Health in Lung Cancer”.

This Presentation is part of the “Bone Health in Cancer Patients in Times of COVID 19” Webinar.

Prof. Dr. Andres Cervantes talks about “Treatment and Patient Care of Metastatic Colon Cancer in Times of COVID 19 in Valencia, Spain”.

This Presentation is part of the “Treatment and Patient Care of Metastatic Colon Cancer in Times of COVID 19” Webinar.

Prof. Dr. Eric Van Cutsem talks about “Management of Colorectal Cancer in COVID Times in Leuven, Belgium”.

This Presentation is part of the “Treatment and Patient Care of Metastatic Colon Cancer in Times of COVID 19” Webinar.

Prof. Dr. Gerald Prager talks about “Treatment and Patient Care of Metastatic Colon Cancer in Times of COVID 19 in Austria”.

This Presentation is part of the “Treatment and Patient Care of Metastatic Colon Cancer in Times of COVID 19” Webinar.

Prof. Dr. Serban Negru talks about “EGFR in Colon Cancer during the COVID 19 Pandemic”.

This Presentation is part of the “Treatment and Patient Care of Metastatic Colon Cancer in Times of COVID 19” Webinar.